UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1987-1992

2008

Volltextzugriff (PDF)

Breast-cancer detection using blood-based infrared molecular fingerprints

BMC cancer, 2021-12, Vol.21 (1), p.1287-9, Article 1287

2021

Volltextzugriff (PDF)

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis

Cancer, 2001-11, Vol.92 (9), p.2247-2258

2001

Volltextzugriff (PDF)

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1980-1986

2008

Volltextzugriff (PDF)

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Journal of clinical oncology, 2003-03, Vol.21 (6), p.968-975

2003

Volltextzugriff (PDF)

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies

NPJ breast cancer, 2021-09, Vol.7 (1), p.124-124, Article 124

2021

Volltextzugriff (PDF)

Curcumin's effect in advanced and metastatic breast cancer patients treated with first or second‐line docetaxel: A randomized trial

Health science reports, 2024-09, Vol.7 (9), p.e70052-n/a

2024

Volltextzugriff (PDF)

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

Cancer, 2002-11, Vol.95 (9), p.2006-2016

2002

Volltextzugriff (PDF)

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Journal of clinical oncology, 2004-10, Vol.22 (19), p.3893-3901

2004

Volltextzugriff (PDF)

Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus

Oncotarget, 2018-04, Vol.9 (28), p.19463-19468

2018

Volltextzugriff (PDF)

Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial

JCO global oncology, 2021-12, Vol.7 (7), p.811-819

2021

Volltextzugriff (PDF)

Long-term safety of aromatase inhibitors in the treatment of breast cancer

Therapeutics and clinical risk management, 2008-02, Vol.4 (1), p.189-204

Nabholtz, Jean-Marc A

2008

Volltextzugriff (PDF)

Taxane/Anthracycline Combinations: Setting a New Standard in Breast Cancer?

The oncologist (Dayton, Ohio), 2001-01, Vol.6 (S3), p.5-12

2001

Volltextzugriff (PDF)

Predictive and prognostic significance of CD8 + tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy

Oncology letters, 2017-07, Vol.14 (1), p.337-344

2017

Volltextzugriff (PDF)

Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

Cancer, 2006-08, Vol.107 (3), p.472-480

2006

Volltextzugriff (PDF)

Monotherapy of Metastatic Breast Cancer: A Review of Newer Agents

The oncologist (Dayton, Ohio), 1999-02, Vol.4 (1), p.17-33

1999

Volltextzugriff (PDF)

Ocular toxicity and cancer chemotherapy: A review

Cancer, 1996-10, Vol.78 (7), p.1359-1373

1996

Volltextzugriff (PDF)

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

Blood, 1999-05, Vol.93 (10), p.3379-3390

1999

Volltextzugriff (PDF)

A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites

Journal of pain and symptom management, 2000-03, Vol.19 (3), p.193-199

2000

Volltextzugriff (PDF)

Third-generation aromatase inhibitors in the treatment of advanced breast cancer

Breast cancer (Tokyo, Japan), 2001-10, Vol.8 (4), p.305-309

2001

Volltextzugriff (PDF)

Main implications related to the switch to BRCA 1/2 tumor testing in ovarian cancer patients: a proposal of a consensus

Oncotarget, 2018-04, Vol.9 (28), p.19463-19468

2018

Volltextzugriff (PDF)

Taxane therapy for early stage breast cancer

Women's Health, 2006-01, Vol.2 (1), p.99-114

2006

Volltextzugriff (PDF)

Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.596-596

2022

Volltextzugriff (PDF)

Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer

Indian journal of surgical oncology, 2010, Vol.1 (1), p.19-26

2010

Volltextzugriff (PDF)

A randomized phase III study of vinflunine versus an alkylating agent of physician’s choice in metastatic breast cancer (MBC) previously treated with or resistant to an anthracycline, a taxane, an antimetabolite and a vinca-alkaloid

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.1031-1031

2015

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

KollektionFree E-Journal (出版社公開部分のみ）

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(20)
Female
(19)
Oncology
(19)
Breast Neoplasms - Drug Therapy
(17)
Breast Neoplasms - Pathology
(11)
Biological And Medical Sciences
(10)
Breast Cancer
(10)
Middle Aged
(10)
Adult
(9)
Medical Sciences
(9)
Aged
(8)
Chemotherapy
(8)
Anastrozole
(7)
Tumors
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Disease-Free Survival
(5)
Docetaxel
(5)
Neoplasm Metastasis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(14)
Cancer
(9)
Cancer Research
(5)
The Oncologist
(3)
The oncologist
(3)
Oncotarget
(2)
Therapeutics And Clinical Risk Management
(2)
Blood
(1)
Bmc Cancer
(1)
Breast
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Breast-cancer detection using blood-based infrared molecular fingerprints

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma : Results of two randomized trials designed for combined analysis

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies

Curcumin's effect in advanced and metastatic breast cancer patients treated with first or second‐line docetaxel: A randomized trial

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus

Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial

Long-term safety of aromatase inhibitors in the treatment of breast cancer

Taxane/Anthracycline Combinations: Setting a New Standard in Breast Cancer?

Predictive and prognostic significance of CD8 + tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy

Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

Monotherapy of Metastatic Breast Cancer: A Review of Newer Agents

Ocular toxicity and cancer chemotherapy: A review

Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane

A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites

Third-generation aromatase inhibitors in the treatment of advanced breast cancer

Main implications related to the switch to BRCA 1/2 tumor testing in ovarian cancer patients: a proposal of a consensus

Taxane therapy for early stage breast cancer

Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant

Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer

A randomized phase III study of vinflunine versus an alkylating agent of physician’s choice in metastatic breast cancer (MBC) previously treated with or resistant to an anthracycline, a taxane, an antimetabolite and a vinca-alkaloid

Aktive Filter

Suchergebnisse filtern